RANKL-blockade for the Treatment of Erosive Osteoarthritis (OA) of Interphalangeal Finger Joints

NCT02771860 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Hand Osteoarthritis

Interventions

DRUG: denosumab
DRUG: Placebo
DIETARY_SUPPLEMENT: Calcium/Vit D supplementation

Sponsor

University Hospital, Ghent

Collaborators

[object Object]